First human test of new drug halted
NCT ID NCT06555601
Summary
This was an early-stage study to test the safety of a new drug called UCB3101 in healthy people. Researchers gave single, increasing doses to small groups of volunteers to see how their bodies reacted and processed the drug. The main goal was to check for side effects and understand how the drug moves through the body. The study has been terminated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UP0124 1
Edegem, Belgium
Conditions
Explore the condition pages connected to this study.